Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON

Toonaangevende leiders

Alle informatieOndernemingenMarktenEconomie & ForexgrondstoffenRenteToonaangevende leidersFinanciŽle professionalAgendaSectoren 
HomepaginaAl het nieuwsHet meest gelezen nieuwsBiografieŽn van de Leiders
Portrait de Thomas W. Hofmann
Leeftijd : 68
Vermogen : 19 681 600 USD
Belangrijkste bedrijven : West Pharmaceutical Services, Inc. - Northern Tier Energy LP
Overzicht 
Thomas W. Hofmann is Chief Financial Officer & Senior Vice President of Sunoco Chemicals, Inc. Mr. Hofmann is also on the board of 10 other companies.

In his past career he was Chief Financial Officer & Senior Vice President of ETC Sunoco Holdings LLC and Director at Northern Tier Energy LLC.

Mr. Hofmann received an undergraduate degree from the University of Delaware and a graduate degree from Villanova University.


Posities en verantwoordelijkheden van Thomas W. Hofmann 
NaamTitel Van
West Pharmaceutical Services, Inc.
(Medische apparatuur, benodigdheden & distributie)
Independent Director 2007
Northern Tier Energy LP
(Olie- en gasraffinage en marketing)
Independent Director -
Sunoco Chemicals, Inc. Chief Financial Officer & Senior Vice President -
Sunoco Logistics Partners Operations LP Director -
PVR GP LLC Independent Director 2013
The Fox Chase Cancer Center Director -
Temple University Health System, Inc. Director -
Young Scholars Charter School Director -
Sunoco Partners LLC Director 2001
The Boys & Girls Clubs of Philadelphia Director -
Scholar Academies Director -


Belangnemingen van Thomas W. Hofmann 
NaamAandelen%Totale waarde
West Pharmaceutical Services, Inc. (WST)
(Medische apparatuur, benodigdheden & distributie)
43 5800,059%19 681 600 USD


Thomas W. HofmannPersoonlijk netwerk 
Meest gelezen nieuws 
15/09BRAD SMITH : Microsoft kondigt inkoop van eigen aandelen aan tot $60 mrd, verhoogt dividend
MR
13/09MARTIN SORRELL : Sorrell's S4 Capital verhoogt winstverwachting tot 40%
MR
14/09STEPHEN SCHERR : Goldman Sachs benoemt Coleman als nieuwe CFO, ter vervanging van Scherr
MR
15/09ILHAM KADRI : Activist Bluebell Capital wil ontslag CEO Solvay
AM
Meer nieuws


© 2021 People and Ownership :   
Thomas W. Hofmann Verbindingen